Disclosure Of Entity's Operating Segments [Text Block]

Sopharma AD - Filing #6139233

Concept	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Disclosure of entity's operating segments [text block]		—	—	—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	1 875 304 BGN	—	—	—	—	—	—	1 663 016 BGN	—	—
Depreciation and amortisation expense	55 872 BGN	—	—	—	—	—	—	52 099 BGN	—	—
Share of profit (loss) of associates and joint ventures accounted for using equity method	24 473 BGN	—	—	—	—	—	—	22 635 BGN	—	—
Tax expense (income)	11 324 BGN	—	—	—	—	—	—	8 743 BGN	—	—
Profit (loss) before tax	111 198 BGN	—	—	—	—	—	—	85 076 BGN	—	—
Profit (loss)	99 874 BGN	—	3 897 BGN	95 977 BGN	95 977 BGN	—	71 121 BGN	76 333 BGN	71 121 BGN	5 212 BGN
Assets	—	1 514 162 BGN	—	—	—	1 253 978 BGN	—	—	—	—
Liabilities	—	760 536 BGN	—	—	—	537 344 BGN	—	—	—	—
Cash flows from (used in) operating activities	45 031 BGN	—	—	—	—	—	—	110 082 BGN	—	—
Cash flows from (used in) investing activities	62 849 BGN	—	—	—	—	—	—	63 606 BGN	—	—
Cash flows from (used in) financing activities	126 842 BGN	—	—	—	—	—	—	64 342 BGN	—	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]